Patents by Inventor Konstantin Holfinger

Konstantin Holfinger has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9370578
    Abstract: The present invention relates to an oral dosage form comprising crystalline lopinavir and crystalline ritonavir. The invention further relates to methods of preparing said oral dosage forms containing the above pharmaceutical active agents.
    Type: Grant
    Filed: March 6, 2013
    Date of Patent: June 21, 2016
    Assignee: ratiopharm GmbH
    Inventors: Dominique Meergans, Konstantin Holfinger
  • Publication number: 20160120869
    Abstract: The present invention relates to a solid pharmaceutical dosage from comprising ticagrelor and ASA as pharmaceutically active agents, to a package for storing the solid pharmaceutical dosage form and to a solid pharmaceutical dosage form for the use in the treatment of certain diseases.
    Type: Application
    Filed: May 23, 2014
    Publication date: May 5, 2016
    Applicant: ratiopharm GmbH
    Inventors: Dirk LEUTNER, Konstantin HOLFINGER, Hans-Juergen MIKA
  • Publication number: 20160081971
    Abstract: The present invention relates to a method for producing a dosage form, preferably a dosage form for immediate release, containing odanacatib wherein the method comprises the granulation with a specific granulation fluid. The invention further relates to a dosage form obtained according to said method.
    Type: Application
    Filed: May 28, 2014
    Publication date: March 24, 2016
    Inventors: Katrin RIMKUS, Konstantin HOLFINGER
  • Publication number: 20150306226
    Abstract: The present invention relates to compositions comprising compound (I) and processes for the preparation thereof.
    Type: Application
    Filed: November 4, 2013
    Publication date: October 29, 2015
    Inventors: Konstantin Holfinger, Sandra Bruck
  • Publication number: 20150017237
    Abstract: The present invention relates to an oral dosage form comprising crystalline lopinavir and crystalline ritonavir. The invention further relates to methods of preparing said oral dosage forms containing the above pharmaceutical active agents.
    Type: Application
    Filed: March 6, 2013
    Publication date: January 15, 2015
    Inventors: Dominique Meergans, Konstantin Holfinger